PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Nanomedicine and Division of Engineering in Medicine, Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.\', \'BWH Center of Excellence for Biomedicine, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, USA.\', \'Center for Stem Cell Therapeutics and Imaging, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, USA.\', \'Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.\', \'Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA, USA.\', \'National Center of Pharmaceutical Technology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.\', \'KACST Center of Excellence for Biomedicine, Joint Centers of Excellence Program, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.\', \'Broad Institute of MIT and Harvard, Cambridge, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/sciadv.aba6884
?:doi
?:hasPublicationType
?:journal
  • Science advances
is ?:pmid of
?:pmid
?:pmid
  • 32832666
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.817
?:rankingScore_hIndex
  • 46
?:title
  • Shattering barriers toward clinically meaningful MSC therapies.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32832666>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32832666>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all